Join Michael Hochman, MD, MPH, for the second episode of Updates in Slow Medicine. This installment discusses results from a recent study that raises the possibility that a…
NEW YORK (Reuters Health) – Continuing bivalirudin for 4 hours after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) facilitates early microvascular reperfusion without an…
NEW YORK (Reuters Health) – A Danish study indicates that among patients undergoing percutaneous coronary intervention, the use of zotarolimus-eluting stents (ZESs) rather than sirolimus-eluting stents (SESs) is…
NEW YORK (Reuters Health) – Administering acetylcysteine to patients before and after they undergo coronary or peripheral angiography does not reduce the occurrence of contrast-induced nephropathy, according to…
NEW YORK (Reuters Health) – The likelihood of refractory ischemia developing in patients with non-ST-segment elevation acute coronary syndrome is reduced if they undergo early rather than deferred…
NEW YORK (Reuters Health) – In patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) prasugrel shows the most favorable benefit-to-risk ratio in the core group of…
NEW YORK (Reuters Health) – Intra-aortic balloon counterpulsation (IABC) to augment blood flow before and for 12 hours after percutaneous coronary intervention (PCI) does not reduce infarct size…
NEW YORK (Reuters Health) – Implantation of cardiac implantable electrophysiological devices (CIED) is associated with increasing rates of complications and mortality, according to results of 3 studies published…
NEW YORK (Reuters Health) – Patients with chronic internal carotid artery occlusion who successfully undergo carotid artery stenting show improvement in global cognitive function, Taiwanese researchers report in…
NEW YORK (Reuters Health) – Asymptomatic carotid artery stenosis does not increase the risk of stroke or mortality after coronary artery bypass graft (CABG) surgery, according to a…
NEW YORK (Reuters Health) – Perioperative treatment with low-dose human atrial natriuretic peptide (carperitide) improves outcomes in patients with chronic kidney disease (CKD) who are undergoing coronary artery…
